March 12, 2014
Dr. Gregory Hoffman's group from Novartis recently used a custom library from Cellecta that identified BRM/SMARCA2 as a critical target in BRG1-deficient cancers (PMID: 24520176). The shRNA library consisted of 6500 shRNAs (380 genes with 17 shRNAs per gene) involved in epigenetic regulation. These genes represented...
Read More